Artemis Hospitals
Glioblastoma treatment cost in India typically runs between 70% and 80% less than in Australia, making it a viable option for those facing high out-of-pocket expenses. A standard brain MRI with contrast costs AUD $577 – AUD $721, while a resection of glioblastoma ranges from AUD $10,814 to AUD $17,014. Total expenses depend on the hospital tier and the specific radiation technology chosen. Bengaluru, Delhi, and Gurgaon are the primary hubs for neuro-oncology.
Typical Glioblastoma Treatment Costs in India
Bookimed Expert Insight: India offers diverse options for oncology patients based on clinical needs. Large networks like Manipal Hospitals provide comprehensive care across 60 departments for complex cases. For those seeking highly specialised Delhi-based care, Apollo Hospital Indraprastha serves as a massive referral centre. Artemis Hospitals uses JCI-accredited systems, providing world-class service for international patients. These clinics use advanced radiation technologies to manage aggressive tumours effectively.
| India | Thailand | Turkey | |
| Gamma Knife | from AUD $6,488 | from AUD $36,046 | from AUD $9,084 |
| Chemotherapy for breast cancer | from AUD $5,046 | from AUD $4,326 | from AUD $1,730 |
| Actinium-225 Therapy | from AUD $12,256 | from AUD $36,046 | from AUD $33,098 |
| Resection of glioblastoma | from AUD $10,814 | - | from AUD $20,763 |
| Halcyon | from AUD $5,479 | - | from AUD $7,786 |
No hidden fees – just official clinic prices. Pay at the clinic for Glioblastoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Glioblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Glioblastoma treatment journey.
The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.
The doctor is a pediatric hematologist-oncologist with a specialization in bone marrow transplantation. With extensive experience in treating pediatric patients with blood disorders and cancers, the doctor has contributed significantly to advancements in this field. The clinical focus includes innovative therapies and patient-centered care, ensuring the best outcomes for young patients. The doctor is recognized for their expertise in managing complex cases and has been involved in numerous clinical trials aimed at improving treatment protocols.
Dr. Raj Nagarkar has performed over 50,000 cancer surgeries at HCG Manavata Cancer Centre. He specializes in breast and thoracic surgical oncology. Dr. Nagarkar trained at the prestigious Tata Memorial Hospital in Mumbai. He is a Member of the Royal College of Surgeons in Edinburgh.
Glioblastoma is currently incurable globally. Indian specialists focus on extending survival and preserving quality of life. Leading centres in Delhi and Bengaluru provide the international standard of care. This includes surgery, radiation, and chemotherapy to manage the disease effectively.
Bookimed Expert Insight: Indian oncology centres often offer high-tech decision support like IBM Watson. This helps doctors match patients with clinical trials or personalised therapies. Large networks like Manipal Hospitals serve 2,000,000 patients annually. This high volume gives their neuro-oncology teams vast experience with complex brain tumours.
Patient Consensus: Patients find that glioblastoma treatment in India focuses on gaining more time and relieving symptoms. Families emphasise checking if treatments are evidence-based rather than experimental before travelling from Australia.
Standard glioblastoma treatment in India follows the internationally recognised Stupp Protocol. This multi-modal approach starts with maximal safe surgical resection. Centres then deliver concurrent chemoradiotherapy followed by adjuvant chemotherapy. Leading hospitals use platforms like Gamma Knife and Halcyon to target tumours while sparing healthy brain tissue.
Bookimed Expert Insight: Surgery remains the foundation, but India's top oncology centres now integrate digital decision-making. Manipal Goa Hospital uses IBM Watson for cancer treatment support. This helps specialists cross-reference a patient's molecular profile with global clinical trials. Australians can find high-volume expertise at Global Hospital Chennai, which performs over 18,000 operations annually.
Patient Consensus: Patients highlight that management starts with surgical resection. They urge others to establish a clear MRI follow-up schedule in India. They also suggest requesting MGMT methylation markers. Finally, they recommend planning for supportive care like nutrition and rehabilitation to manage radiotherapy-related fatigue.
Indian oncology centres report a median overall survival for glioblastoma of 10 to 17 months. One-year survival rates typically range from 30% to 62%. Achieving these outcomes depends on maximum safe surgical resection. Patients must also finish the standard chemoradiation protocol.
Bookimed Expert Insight: High-volume networks like Manipal Hospitals and Apollo serve over 1,000,000 patients annually. This scale allows for dedicated neuro-oncology departments. Specialists like Dr Vikas Gupta focus exclusively on brain tumours. Australian patients benefit from these centres holding JCI accreditation. This accreditation means safety standards match Western private hospitals.
Patient Consensus: Patients emphasise checking MGMT and IDH status before comparing survival statistics for India. They recommend planning follow-up MRI checks with an Australian GP before starting overseas treatment.
India offers radiation for glioblastoma, including Proton Beam Therapy at dedicated centres like Apollo Proton Cancer Centre. Facilities also provide Gamma Knife radiosurgery and Halcyon platforms. Specialist neuro-oncologists use these technologies to spare healthy brain tissue while targeting aggressive tumours.
Bookimed Expert Insight: Indian oncology hubs often combine proton therapy with specialised diagnostics. HCG Manavata Cancer Centre has handled over 30,000 PET scans. This volume helps specialists like Dr Sridhar P.S. precisely map glioblastoma borders before starting radiotherapy.
Patient Consensus: Patients note that proton therapy is niche and centre-dependent. They say accessing dedicated neuro-oncology teams in major Indian cities is vital. They recommend confirming if planning like IMRT or IGRT is included in the glioblastoma protocol.
International patients typically stay in India for 3 to 10 weeks. Surgery alone requires 3 to 4 weeks for recovery and neurological stability. Patients staying for the full initial protocol, including radiation and chemotherapy, need about 12 to 14 weeks.
Bookimed Expert Insight: Patients can access decision-support tools like IBM Watson at Manipal Hospitals to streamline treatment paths. This technology helps specialists select the most effective protocols quickly. Using such tools may reduce the initial diagnostic window. This helps patients start the appropriate phase of treatment sooner during their stay.
Patient Consensus: Patients suggest keeping itineraries flexible as pathology results often change the schedule after surgery. It is important to factor in extra time for wound healing and steroid tapering. Patients should also allow for follow-up imaging in India before flying home.